ADVERTISEMENT

From the Desk of the CEO

James Keagy
/ Categories: CEO Blog

What Canada can teach us about the pharmacy team

Today’s pharmacy workflows in both the community and health-system settings sometimes baffle me given they have remained largely the same for decades. Recently, on a trip to Montreal, I visited a community pharmacy. Despite being a short drive from the US border, it seemed as though I was in a different world altogether. The entire layout and design of the pharmacy area was completely different. The atmosphere conveyed professionalism from the moment I walked into the building, from the layout, sounds, and how the staff carried out their work. This was in a Jean Coutu group pharmacy, one of the largest chains in Quebec.

Despite the pharmacy filling about 1,200 prescriptions a day, the environment was organized, polished, and not at all chaotic. Behind the pharmacy counters, pharmacists were working, not standing but seated at computers, assessing patient profiles and ensuring appropriateness of prescribed therapies. Technicians were engaged in another area, aided tremendously by robotic technologies, and dispensing medications. Interestingly, pharmacists in the pharmacy are actually told NOT to touch the medications…their role is medication therapy expert, meaning their focus is on medication safety and optimal outcomes from patient-specific therapies. Reimbursement includes calculation of the pharmacist’s time to conduct the clinical accuracy assessment. As such, the health care system appropriately reimburses the practice sufficiently for the product and the cognitive clinical services provided by the pharmacist.

When a patient needs to consult with a pharmacist, or the pharmacist needs to speak with a patient, the conversation doesn’t happen at the cash register. Pharmacists aren’t permitted to be there either—the technician or clerk makes a quick patient care assignment to the pharmacist in queue, the patient has a seat, and the pharmacist calls the patient to a more private consultation window for the conversation. Depending upon the nature of the consult, the pharmacist may need to do further assessment, may schedule the patient for an in-depth encounter, and then may prescribe the necessary treatment or refer. This also results in payment from the health plan. The patient knows and feels that health care has been provided. This doesn’t feel like “retail” at all…it feels very much like a professional pharmacy practice. I learned that this pharmacy and experience is the norm in Quebec, and in most Canadian provinces.

Many US pharmacies can feel, quite simply, a little chaotic. I wish there were a gentler way to say it, but for many Americans, a trip to the pharmacy often feels more like a retail transaction than a personal interaction. The goal is simple: help me get what I need and, with a little luck, get me on my way quickly. I may even give the drive-through a try!

(Did you know that in Quebec, pharmacists do not provide advice or consultation at the drive-through? If you have a question for the pharmacist, you can call for a telephone consultation or you can come into the pharmacy for a visit.)

Why is it that we have such a dichotomy of experiences in North America? You’d think that the border between our countries was an ocean and not simply a check point! At the risk of putting it too simply, if we want America’s community pharmacies to feel a little more like their Canadian counterparts, we’ll need to get comfortable with some meaningful change. It may not be easy, but it is a conversation worth having.

First, we must separate the act of dispensing medications from the cognitive clinical care provided by the pharmacist. I know this sounds like a broken record and just exactly like what your university professor told you might happen someday, but the time is here. We’ve got to take a critical look at the science of safely dispensing patient-optimized medications and recognize that pharmacists being involved in the physical act of filling prescriptions isn’t the most critical role they have in health care. With an aging population and a pharmacist shortage, we can no longer afford to have pharmacists routinely handle prescriptions. We need pharmacists to fulfill their role as the medication expert by ensuring appropriate medication outcomes and optimizing medication therapy to help patients live their best lives.

Secondly, state boards of pharmacy need to act now. We can’t wait any longer. The purpose of a state board of pharmacy is to protect the public’s health and well-being. Limiting the use of technology in dispensing in any way at all is simply unfounded. In fact, it may be putting patients in danger of greater harm. Without technology and the effective use of pharmacy technicians, pharmacists are left performing tasks well below their level of education, training, and experience. Burdening them with a tedious process, growing workloads, and inadequate staffing takes time away from their true public health role: protecting patient safety and promoting the appropriate use of medications.

If we want to solve the staffing crisis in pharmacy, we must optimize technology in practice while lifting the roles of pharmacists and technicians. Corporations will integrate technology optimally when there are no regulatory barriers to doing so.

Third, state boards need to rethink the pharmacy technician equation. Ratios for staffing are not the solution. The solution is to ensure technicians have the education, training, and certifications necessary to support the pharmacist and verify that medications are dispensed safely and appropriately to the patient. This teamwork affords the pharmacist the time to provide comprehensive medication-related care to the patient. This may mean increasing our commitment to PTCB certification, increasing our expectations for education and training of technicians, and supporting the practice of technicians based upon science of safety and not based upon emotion or fear. It also means that employers must pay pharmacy technicians a living wage with consistent hours.

Given the country’s severe shortage of primary care professionals—and growing calls for pharmacists to help fill that gap—there is little reason to fear that pharmacy technicians will take pharmacists’ jobs. The goal is not to shift work away from pharmacists, but to ensure pharmacists can devote more time and attention to the patient care activities that only they are trained and licensed to provide.

I’m certain this blog has stirred some emotions. Solving this problem will take far more than the three ideas I’ve outlined here. My aim isn’t to make people angry, but to get them thinking. If the Canadians have found a way forward (and they have), surely America can, too. Join us, at APhA, collaborating across the profession to create solutions.

For all of pharmacy.

Previous Article Remembering Jack Schlegel, former APhA CEO
Print
1722
Please login or register to post comments.

Featured Post

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

All Posts

Posted: Oct 8, 2026

What Canada can teach us about the pharmacy team

In his latest blog, APhA CEO Michael Hogue explores how technology, pharmacy technicians, and modernized workflows can help transform pharmacy practice and enable pharmacists to focus on the patient care services only they are trained and licensed to provide. Drawing from a visit to a high-volume community pharmacy in Quebec, Hogue highlights a care model where pharmacists concentrate on medication management, clinical decision-making, and patient consultations, while technology and qualified technicians support dispensing operations.

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Oct 23, 2026

Kratom’s risks deserve our attention

Brigid Groves, PharmD, MS, Vice President, Professional Affairs, APhA

A patient seeking relief may not recognize the risks of a product within easy reach. Brigid K. Groves, PharmD, MS, APhA’s Vice President, Professional Affairs, shares why kratom and concentrated 7-OH products deserve pharmacists’ attention and how a simple conversation can help protect patients from harm.

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement